New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
09:12 EDTACH, EMR, ZNGA, PSMI, TTWO, PSEC, NUS, ARMH, BSX, FURX, ENTG, KORS, ATMI, AEIS, JCPOn The Fly: Pre-market Movers
HIGHER: Michael Kors (KORS), up 21% after Q3 earnings beat expectations, company raises guidance... Furiex (FURX), up 124% after reporting top-line results for its Phase III trials evaluating its irritable bowel syndrome treatment... Zynga (ZNGA), up 7% following upgrade at UBS... J.C. Penney (JCP), up 3.5% after reporting positive Q4 comparable store sales... Nu Skin (NUS), up 2% after Q4 EPS and revenue view top expectations... ATMI (ATMI), up 25% after peer Entegris (ENTG) agrees to acquire company for $34.00 per share. Entegris shares also up 17% after deal announcement, while others in the sector, such as Advanced Energy Industries (AEIS) also rose... DOWN AFTER EARNINGS: ARM Holdings (ARMH), down 6.8%... Arch Coal (ACI), down 1.8%. ALSO LOWER: Take-Two (TTWO), down 6% after earnings report, downgrades at Wedbush and Benchmark... Peregrine (PSMI), down 16% after earnings, downgrades at Needham and JPMorgan.
News For KORS;JCP;ATMI;ENTG;AEIS;NUS;ZNGA;FURX;PSEC;EMR;BSX;TTWO;ACH;ARMH;PSMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 20, 2015
16:09 EDTBSXBoston Scientific announces long-term data underscore safety, efficacy of S-ICD
The Journal of the American College of Cardiology published data confirming the long-term safety and efficacy of the Boston Scientific S-ICD System for patients at risk of sudden cardiac arrest. The study, "Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry" was led by Dr. Martin Burke, professor of medicine at the University of Chicago. The analysis combined data from two large S-ICD studies to provide the most comprehensive look at S-ICD System patient outcomes to date. The all-cause mortality rate for the S-ICD patients was 1.6% per year, comparing favorably to observed mortality rates in similar TV-ICD studies. Currently, the S-ICD System is covered nationally by Medicare, Aetna, Cigna and others, and regionally by numerous private and Medicaid plans, providing coverage for approximately 170M individuals in the U.S. The S-ICD System has been commercially available in Europe since 2009.
10:29 EDTPSECOptions with increasing implied volatility: PNK PSEC TWC
Subscribe for More Information
10:00 EDTKORSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:18 EDTKORSMichael Kors downgraded to Neutral with $70 target at Mizuho
Subscribe for More Information
07:44 EDTBSXSurvey shows strong momentum for Boston Scientific devices, says RBC Capital
RBC Capital says that its survey supports strong momentum for Boston Scientific's S-ICD and Watchman, and the firm thinks the company is probably gaining share in single-chamber ICDs. The firm raised its price target on the shares to $20 from $17 and recommends buying the shares at current levels or on pullbacks.
06:11 EDTKORSMichael Kors downgraded to Neutral from Buy at Mizuho
Subscribe for More Information
06:10 EDTKORSMichael Kors implied volatility of 24 at lower end of index mean range
April 17, 2015
07:15 EDTTTWOMarch NPD video game software sales declined 3%, says Piper Jaffray
Piper Jaffray notes March NPD video game software sales declined 3% year-over-year, with major titles for the month including Electronic Arts' (EA) Battlefield Hardline, Bloodborne from Sony (SNE) and Take-Two's (TTWO) Grand Theft Auto V. Piper notes the monthly decline is the first in 2015, leaving the segment up 2% through the first three months combined. It keeps Overweight ratings on Activision Blizzard (ATVI), Electronic Arts, GameStop (GME) and Take-Two.
April 16, 2015
16:44 EDTAEISAdvanced Energy appoints
Advanced Energy announced that Thomas Liguori, currently CFO and executive vice president at Multi-Fineline Electronix, will join the company as CFO and executive vice president on May 18.
16:11 EDTBSXBoston Scientific enrolls first patient REDUCE-HTN: REINFORCE study
Boston Scientific announced the first patient in the REDUCE-HTN: REINFORCE study was enrolled this week at Cardiology P.C. at Princeton Baptist Medical Center in Birmingham, AL by Farrell Mendelsohn, M.D., site principal investigator, and referred by Michael Wilensky, M.D. Boston Scientific received an investigational device exemption, or IDE, for the study from the FDA in December.
09:55 EDTKORSMichael Kors view changed to Mixed from Positive at OTR Global (pre-open)
Subscribe for More Information
05:55 EDTKORSCoach upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Joan Payson upgraded Coach to Overweight citing greater confidence in the designer's ability to grow domestic store comps with its turnaround "well underway." She expects Coach's competitive pressures to ease and raised her price target for shares to $50 from $38. The maker of handbags closed yesterday down 28c to $41.76. Payson also lowered her price target for shares of Michael Kors (KORS) to $60 from $70 and keeps an Equal Weight rating on the name. She believes Kors may soon be in need of transformation. The analyst keeps an Equal Weight rating on Tiffany (TIF), calling the company a "work in progress."
05:28 EDTARMHARM announces the acquisition of Wicentric and Sunrise Micro Devices
ARM announced the acquisition of Wicentric, a Bluetooth Smart stack and profile provider, and Sunrise Micro Devices, a provider of sub-one volt Bluetooth radio intellectual property. Terms of the agreements have not been disclosed. The IP of both companies will be integrated to form the ARM® Cordio portfolio. The ARM Cordio portfolio is available for immediate licensing.
April 15, 2015
11:09 EDTJCPJ.C. Penney rally would be opportunity to issue shares, says Imperial Capital
Imperial Capital continues to expect elevated debt levels to erode the value of J.C. Penney shares, but it thinks favorable operating momentum could drive the stock price above $10. Imperial believes such a rally would provide Penny with a "great opportunity" to issue additional shares to pay down debt. The firm keeps an Underperform rating on Penny with a $3 price target. Shares of the retailer are up 9c to $9.23 in late morning trading.
April 14, 2015
11:47 EDTJCPJ.C. Penney business on 'more stable footing,' says Baird
Baird analyst Mark Altschwager says J.C. Penney's business is on "more stable footing" after the retailer reported a quarter-to-date comp of 6% and provided Q1 comp guidance above consensus. Altschwager raised his price target for shares to $10 from $9 but keeps a Neutral rating on Penny. He believes meaningful free cash flow growth will be challenging as investment needs normalize.
10:50 EDTPSECOptions with increasing implied volatility
Subscribe for More Information
09:09 EDTBSXBoston Scientific announces strategic alliance with Frankenman
Boston Scientific announced the signing of a strategic alliance with Frankenman Medical Equipment Company, a recognized leader with deep local market expertise in the China surgical devices market. This alliance is expected to enable Boston Scientific and Frankenman to reach more clinicians and treat more patients by providing access to training on less invasive endoscopic technologies and the clinical and economic benefits these therapies can provide. CPEChina Fund, an entity of CITIC PE, is a current shareholder of Frankenman and will continue to support the company's growth in alignment with this strategic partnership.Under the terms of the agreement, Boston Scientific will become a shareholder of Frankenman, and provide services and expertise to Frankenman to support its continued growth, development pipeline and manufacturing capabilities. The transaction is expected to close in the first half of 2015, subject to customary closing conditions.
08:55 EDTJCPJ.C. Penney sees Q1 SSS up 3.5%-4.5%
J.C. Penney said in a regulatory filing that on April 13, the company became aware that a senior official of the company inadvertently sent an e-mail communication to a securities analyst that contained non-public information regarding the company’s comparable store sales results for Q1 to date, which are approximately 6%. Based on results to date, and taking into account the shift of Easter into the fiscal month of March this year, the company currently expects comparable store sales for Q1 to be in the range of 3.5%-4.5%.
April 13, 2015
10:12 EDTEMREmerson CEO willing to undertake strategic actions, says Credit Suisse
Subscribe for More Information
06:22 EDTJCPGap, Target, others scrutinized by NY AG over staffing practices, WSJ says
Several major retailer including Gap (GPS) and Target (TGT) are under investigation by New York Attorney General Eric Schneiderman over their staffing practices and whether they require workers to show up or stay home with little notice, The Wall Street Journal reports. Schneiderman sent letters warning Abercrombie & Fitch (ANF), JC Penney (JCP), Urban Outfitters (URBN), TJX Cos (TJX), Ann Inc (ANN), L Brands (LB), Burlington Stores (BURL), Sears Holdings (SHLD), Williams-Sonoma (WSM) and J Crew Group that he believes the chains are using on-call scheduling and that such practices may be in violation of New York laws. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use